JNJ vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-07.
Johnson & Johnson · Healthcare
$230.69
+10.8% upside to fair value
Grade C
High Quality
VS
Palantir Technologies Inc. · Technology
$133.79
-41.7% upside to fair value
Grade C
High Quality
QuantHub Verdict
JNJ has more upside to fair value
(+10.8%).
JNJ trades at a lower forward P/E
(26.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
PLTR |
| Current Price |
$230.69 |
$133.79 |
| Fair Value Estimate |
$255.61 |
$78.04 |
| Upside to Fair Value |
+10.8%
|
-41.7%
|
| Market Cap |
$555.9B |
$306.6B |
| Forward P/E |
26.8x
|
140.4x
|
| EV / EBITDA |
18.5x
|
151.4x
|
| Price / Sales |
5.8x
|
58.7x
|
| Price / FCF |
28.2x
|
114.0x
|
| Revenue Growth YoY |
+9.9%
|
+84.7%
|
| Gross Margin |
69.1%
|
84.1%
|
| Operating Margin |
26.9%
|
38.1%
|
| Return on Equity |
26.5%
|
32.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.54%
|
0.88%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,…
Palantir Technologies Inc. is a high-growth enterprise software company specializing in data analytics and intelligence platforms for government and commercial clients. The company benefits from a durable competitive moat through its established government contracts, proprietary platforms Gotham and Foundry, and expanding commercial footprint. Palantir's revenue grew 84.7% year-over-year in the m…
Accumulation Zones
| Metric |
JNJ |
PLTR |
| Zone Low |
$191.71 |
$58.53 |
| Zone High |
$217.27 |
$66.33 |
| In Buy Zone? |
No
|
No
|